ABSTRACT PURPOSE: The role of Ureaplasma urealyticum (U. urealyticum), Mycoplasma hominis (M. hominis) and Mycoplasma genitalium (M. genitalium) in male genital disorders deserves a more intensive research. The aim of this study was to determine the prevalence rate of these pathogens in symptomatic and asymptomatic sexually active males in Bulgaria.
INTRODUCTION
Genital mycoplasmas belong to the sexually transmitted infections that more and more frequently cause acute diseases, long-term disability and infertility. However, these pathogens are not included in the routine microbiological diagnosis. Nowadays polymerase chain reaction (PCR) is the method of choice for their identification.
The aim of this study was to establish the prevalence and clinical significance of U. urealyticum, M. hominis and M. genitalium in symptomatic and asymptomatic sexually active men in Bulgaria by PCR examinations of their urethral swabs.
MATERIAL AND METHODS
The study covered a total of 260 males. A written informed consent to participate in the study was obtained from each person. Dacron swabs were used to collect urethral specimens for the detection of the bacteria. They were put into a special transport medium. The samples were transported within ~1 hour to the laboratory and examined either within the same day, or no longer than one week later on.
Aliquots of the transport medium with the sample were used for PCR testing for the detection of fragments of U. urealyticum, M. hominis and M. genitalium. After vortexing the diluted sample was subjected to a DNA extraction using DNA extraction kit according to manufacturer's requirements (Sacace Biotechnologies, Como, Italy). Detection of the pathogens was performed by applying PCR spe-cific primers according to Lee et al. (11) . PCR was carried out with 4 µL of the template DNA, 0,25 µL of each primer (Alpha DNA, Canada), 0,2 mM (each) of the deoxyribonucleoside triphosphates, 1x Reaction Buffer, MgCl 2 (2 mM) and 1,5 U of Taq DNA polymerase (Prime TaqTM DNA Polymerase; GEN-ET BIO) in a total volume of 25 µL. The DNA was amplified in a Techgen PCR thermocycler (Techne, England) using the following protocol: an initial denaturation 94 ºC, 5 min; 35 cycles (94 ºC, 40 sec; 54 ºC, 45 sec; 72 ºC, 1 min 5 sec) and final extension 72 ºC, 7 min. PCR products (12,5 µL of each amplification) were separated in a 1,5% agarose gel for 45 min at 150 V, stained with ethidium bromide (0,5 µg/mL) and detected using UV transillumination (λ=312 nm). Each PCR run was accompanied by a quality control. For positive control, U. urealyticum ATCC-33699, M. hominis ATTC-14027 and M. genitalium ATCC-33530 were used. The negative controls included distilled water and negative clinical samples selected at random.
Each DNA was subjected to a human β-globin PCR to ensure that amplifiable DNA was successfully extracted from the sample and to monitor for PCR inhibitors (4). This β-globin PCR protocol was the same one listed for bacterial PCR, with the exception that the following primers were employed: GH2O, 5'-GAAGAGCCAAGGACAGG TAC-3', and PCO4, 5'-CAACTTCATCCACGTTCACC-3'.
RESULTS
The swabs received from persons with or without any genital complaints were used to evaluate the prevalence rate of U. urealyticum, M. hominis and M. genitalium infection.
U. urealyticum was found out in 12 swabs (in 4,6%), M. hominis -in two samples (in 0,8%), and M. genitalium -in 8 symptomatic males (in 3,1%) ( Table  1) . Coinfections were not detected at all. The higher relative share of positive findings was established in the symptomatic group of U. urealyticum and M. genitalium.
DISCUSSION
In men, Ureaplasma spp. are the main cause of nonchlamydial, nongonococcal urethritis and acute prostatitis (3) M. genitalium is associated with urethritis (7, 8, 10) , too, whereas M. hominis is related to pyelonephritis (3). Although genital mycoplasmas are established as relevant sexually transmitted pathogens little is known about these infections in Bulgarian males.
It is considered that M. hominis does not provoke urogenital disorders except in 5% of the cases with pyelonephritis (17). There are contradictory opinions about the infertility caused by this microorganism. Some investigators register a prevalence rate of 1,3% of the infection among patients attending infertility clinics (9) , while others detect a higher one -of 10,8% (6). In our study, M. hominis is proved in one male attending the Clinic for a prophylactic check-up.
U. urealyticum is another genital microorganism which prevalence rate among healthy men varies in a wide range -between 0% and 56% (12) . The pathogen is detected in 5,6-42% among the patients with urethritis (5) and in 15-20,1% among those with infertility. In our study, its prevalence rate is 4,6%.
In our study, M. genitalium prevalence rate is 3,1%. Other authors establish a low prevalence rate of the infection in sexually active persons, too -0,98% (13); 0,8% (2); 1,3% (15); 2,3% (1), and 3,7% (14) . Significantly higher literature data are reported concerning the symptomatic patients with acute nongonococcal urethritis between 13,2% and 33,3% (16) and the persons with complains but without urethritis -between 0% and 9,1% (18 There are scanty data about the prevalence rates, diagnostic methods and clinical significance of mycoplasmas in Bulgaria. In this respect, males are first examined in our country. The relatively lower prevalence rates of these three infections in Bulgaria than those reported elsewhere could be due to the less expressed circulation of these pathogens as well as to the widespread usage of macrolides in our clinical practice.
CONCLUSION
U. urealyticum and M. genitalium are established in symptomatic patients only while M. hominis is detected in two patients attending the clinic for prophylactic checkup. The present investigation of these mycoplasmas is the first attempt to provide certain epidemiological information about these infections in Bulgaria. Their continuous monitoring is of practical importance for public health.
